Phase II study of RAD001 (everolimus) in patients with metastatic renal cell cancer
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- Acronyms RAD001
- 10 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 24 Aug 2008 Planned end date changed to 1 Aug 2009.
- 24 Aug 2008 Status changed from recruiting to active, no longer recruiting.